0001104659-24-037934.txt : 20240322
0001104659-24-037934.hdr.sgml : 20240322
20240322170040
ACCESSION NUMBER: 0001104659-24-037934
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240320
FILED AS OF DATE: 20240322
DATE AS OF CHANGE: 20240322
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bhatt Padmanabh P.
CENTRAL INDEX KEY: 0001539215
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35518
FILM NUMBER: 24776057
MAIL ADDRESS:
STREET 1: C/O SUPERNUS PHARMACEUTICALS, INC.
STREET 2: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001356576
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-838-2500
MAIL ADDRESS:
STREET 1: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060317
4
1
tm249377-2_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-03-20
0
0001356576
SUPERNUS PHARMACEUTICALS, INC.
SUPN
0001539215
Bhatt Padmanabh P.
C/O SUPERNUS PHARMACEUTICALS, INC.,
9715 KEY WEST AVENUE
ROCKVILLE
MD
20850
0
1
0
0
Sr. VP of IP, CSO
1
Common Stock
2024-03-20
4
M
0
400
25.30
A
8970
D
Common Stock
2024-03-20
4
S
0
400
35.31
D
8570
D
Employee Stock Option (Right to Buy)
25.30
2024-03-20
4
M
0
400
0
D
2027-02-24
Common Stock
400
27236
D
Transaction made pursuant to a 10b5-1 trading plan adopted September 7, 2023.
The option vested in four equal annual installments beginning on February 24, 2018.
/s/ Timothy C. Dec, as attorney-in-fact
2024-03-22